Literature DB >> 1708341

Differential activation of human basophils by anti-IgE and formyl-methionyl-leucyl-phenylalanine. Indications for protein kinase C-dependent and -independent activation pathways.

E F Knol1, L Koenderman, F P Mul, A J Verhoeven, D Roos.   

Abstract

Upon activation, basophilic granulocytes release inflammatory mediators such as histamine. We studied histamine release of human basophils (64.1 +/- 9.6% pure) after cross-linking of membrane-bound IgE via anti-IgE, or after binding of the chemoattractant formyl-methionyl-leucyl-phenylalanine (fMLP). A variability in the extent of histamine release upon stimulation by either anti-IgE or fMLP was found between donors. Kinetic studies revealed that the histamine release induced by anti-IgE (t1/2 greater than 240 s) was more than 20-fold slower than the almost instantaneous release upon stimulation with fMLP (t1/2 less than 10 s). Differences in the cell activation pathways triggered by these stimuli were further analyzed with staurosporine, an inhibitor of protein kinase C (PKC) and with wortmannin, an inhibitor of a PKC-independent pathway. Inhibition of PKC resulted in a partial inhibition of the anti-IgE-induced release, whereas the fMLP-induced release was slightly potentiated. The anti-IgE-induced release was completely inhibited in the presence of wortmannin. This inhibitor too, had no effect on the fMLP-induced release. We conclude that major differences exist in the signal-response coupling between the anti-IgE and fMLP-induced histamine release in human basophils. The so-called releasability of human basophils may be due to the availability of different cell activation pathways.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1708341     DOI: 10.1002/eji.1830210404

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Unreliable measurement of basophil maximum leukotriene release with the Bühlmann CAST 2000 enzyme-linked immunosorbent assay kit.

Authors:  S E Burastero; C Paolucci; D Breda; G Monasterolo; R E Rossi; L Vangelista
Journal:  Clin Vaccine Immunol       Date:  2006-03

2.  Diclofenac induces basophil degranulation without increasing CD63 expression in sensitive patients.

Authors:  A Malbrán; E Yeyati; G L Rey; N Galassi
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 3.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

Review 4.  Response to Ebo et al., Letter to the Editor Regarding Update on Quinolone Allergy.

Authors:  Inmaculada Doña; Esther Moreno; Natalia Pérez-Sánchez; Inmaculada Andreu; Dolores Hernández Fernandez de Rojas; María José Torres
Journal:  Curr Allergy Asthma Rep       Date:  2017-10-04       Impact factor: 4.806

5.  Distribution of retroviral p15E-related proteins in neoplastic and non-neoplastic human tissues, and their role in the regulation of the immune response.

Authors:  R A Scheeren; R A Oostendorp; S van der Baan; R M Keehnen; R J Scheper; C J Meijer
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

6.  A pH-stabilizing role of voltage-gated proton channels in IgE-mediated activation of human basophils.

Authors:  Boris Musset; Deri Morgan; Vladimir V Cherny; Donald W MacGlashan; Larry L Thomas; Eduardo Ríos; Thomas E DeCoursey
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-29       Impact factor: 11.205

7.  Pharmacological investigations with different protein kinase C inhibitors on IgE-dependent and IgE-independent activation of human basophils.

Authors:  U Amon; E von Stebut; H H Wolff
Journal:  Agents Actions       Date:  1993-05

8.  Development of a microarray-based method to detect exposure of human basophils to IL-3.

Authors:  Donald MacGlashan
Journal:  J Immunol Methods       Date:  2012-08-14       Impact factor: 2.303

9.  Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy.

Authors:  Niya Wanich; Anna Nowak-Wegrzyn; Hugh A Sampson; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

10.  Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by Fc epsilon R1 cross-linking.

Authors:  S A Barker; K K Caldwell; A Hall; A M Martinez; J R Pfeiffer; J M Oliver; B S Wilson
Journal:  Mol Biol Cell       Date:  1995-09       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.